Bifogade filer
Prenumeration
Beskrivning
| Land | Sverige |
|---|---|
| Lista | Nordic SME Sweden |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
Intresserad av bolagets nyckeltal?
Analysera bolaget i Börsdata!
Vem äger bolaget?
All ägardata du vill ha finns i Holdings!
THE INFORMATION IN THIS PRESS RELEASE MAY NOT BE ANNOUNCED, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, INTO AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA, THE UNITED KINGDOM, THE UNITED STATES OR ANY OTHER JURISDICTION WHERE THE RELEASE, PUBLICATION OR DISTRIBUTION OF THE INFORMATION WOULD BE CONTRARY TO OR REQUIRE REGISTRATION UNDER APPLICABLE REGULATIONS.
Lumito AB (publ) ("Lumito" or the "Company") has completed the rights issue of units consisting of shares and warrants with preferential rights for existing shareholders (the "Rights Issue"), which the Board of Directors resolved on September 9, 2025, and which was approved by the Extraordinary General Meeting on October 10, 2025. In accordance with the guarantee agreements entered into in connection with the Rights Issue, the Board of Directors resolved on November 11, 2025, on a directed share issue of units to the guarantors in the Rights Issue (the "Compensation Issue"). The subscription price in the Compensation Issue amounts to the same subscription price as in the Rights Issue, SEK 0.025 per share, and payment is made by set-off of the guarantors' claims regarding guarantee compensation. In total, 18,699,984 shares and 12,466,656 warrants of series TO7 will be allotted to the guarantors in the Compensation Issue.
The rights issue carried out by Lumito AB was secured through subscription commitments and guarantee commitments to approximately 60 percent. For underwriting guarantees, a consideration of fifteen (15) percent of the underwritten amount can be paid in cash or seventeen (17) percent of the underwritten amount in units, with the same terms and conditions as for units in the Rights Issue. In view of this, the Board of Directors has, based on the authorization granted by the Extraordinary General Meeting on October 10, 2025, resolved on the Compensation Issue, which in total comprises 18,699,984 shares and 12,466,656 warrants of series TO7. The subscription price amounts to SEK 0.025 per share, corresponding to the subscription price in the Rights Issue.
The reason for the deviation from the shareholders' preferential rights in the Compensation Issue is to fulfil the Company's contractual obligation towards the guarantors. The Board of Directors believes that it is to the advantage of the Company's financial position to take advantage of the opportunity to pay the guarantee fee in the form of units instead of through cash payment as this has a positive effect on the Company's liquidity. Payment in the Compensation Issue is made by set-off of the guarantors' claim for guarantee compensation. The subscription price in the Compensation Issue was negotiated at arm's length in connection with the procurement of the guarantee commitments, which was done in consultation with the financial advisor and after an analysis of customary market factors. The Board of Directors' assessment is that, against this background, the subscription price is market-secured.
Shares, share capital and dilution
Through the Compensation Issue, and after registration of the Rights Issue, the total number of shares in the Company will increase by 18,699,984 shares, from 1,701,748,167 shares to 1,720,448,151 shares, corresponding to a maximum dilution effect of 1 percent of the number of shares and votes in the Company. The share capital will increase by approximately SEK 467,499.600, from approximately SEK 42,543,704.175 to SEK 43,011,203.775.
Advisers
Mangold Fondkommission AB is acting as financial advisor and Advokatfirman Lindahl KB is acting as legal advisor to Lumito in connection with the Rights Issue.